A potential new treatment for mental health disorders
January 4, 2022
The University of Cincinnati's Dr. Ishita Basu is researching how targeted electrical stimulation can be used as a treatment for mental health disorders.
January 4, 2022
The University of Cincinnati's Dr. Ishita Basu is researching how targeted electrical stimulation can be used as a treatment for mental health disorders.
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.
September 20, 2021
Amanda Jackson, MD, associate professor and director of gynecologic oncology, spoke with Angenette Levy of 55KRC on the Simply Medicine podcast to discuss Ovarian Cancer Awareness Month.
November 16, 2021
Researchers at the University of Cincinnati are leading the largest-ever NIH stroke recovery study, examining if certain biomarkers can help predict patient recovery.
December 9, 2021
University of Cincinnati researchers are leading the FASTEST global trial that will examine the effectiveness of a new treatment for strokes due to intracerebral hemorrhage.
December 14, 2021
The University of Cincinnati's Dr. Soma Sengupta was featured in WFRV's HealthWatch segment highlighting the pilot study of a music therapy app to help lift patients' brain fog.
October 14, 2021
UC's Dr. Annie Brown discusses breast cancer screening recommendations for transgender patients and ways to make care more accessible and equitable.
October 14, 2021
UC's Dr. Rhonna Shatz is featured in a Well + Good article exploring certain brain functions that can sometimes improve as we age.
January 26, 2022
Innovate Healthcare featured comments from University of Cincinnati radiologists Achala Vagal and Luca Saba in an article about the future of how artificial intelligence can help move stroke care forward.
March 9, 2022
Inside Precision Medicine featured recent University of Cincinnati research led by Dr. Trisha Wise-Draper showing adding immunotherapy to standard of care treatments for head and neck cancer increased survival rates for intermediate risk patients.